Global
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 15.26 B
|
Dec. 31, 2023 | USD 55.74 | 0.69% |
|
United States |
|
2 |
USD 11.18 B
|
Dec. 31, 2023 | USD 26.41 | -1.46% |
|
United States |
|
3 |
USD 11.15 B
|
Dec. 31, 2023 | USD 175.55 | -0.67% |
|
United States |
|
4 |
USD 10.32 B
|
Dec. 31, 2023 | USD 20.20 | -1.60% |
|
Germany |
|
5 |
USD 9.66 B
|
Dec. 31, 2023 | USD 556.99 | 0.27% |
|
United States |
|
6 |
USD 9.38 B
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
7 |
USD 8.41 B
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
8 |
USD 7.94 B
|
Dec. 31, 2023 | USD 267.10 | -1.14% |
|
United States |
|
9 |
USD 5.67 B
|
Dec. 31, 2023 | USD 690.87 | -3.63% |
|
United States |
|
10 |
USD 5.49 B
|
Dec. 31, 2023 | USD 60.89 | 1.60% |
|
United States |
|
11 |
USD 4.66 B
|
Dec. 31, 2023 | USD 91.00 | 1.18% |
|
United States |
|
12 |
USD 4.39 B
|
Dec. 31, 2023 | USD 145.16 | 0.75% |
|
Germany |
|
13 |
USD 3.92 B
|
Dec. 31, 2023 | USD 237.62 | -0.94% |
|
United States |
|
14 |
USD 3.81 B
|
Dec. 31, 2023 | USD 3.45 | 3.36% |
|
China |
|
15 |
USD 3.77 B
|
Dec. 31, 2023 | USD 362.80 | 0.50% |
|
United States |
|
16 |
USD 3.41 B
|
Dec. 31, 2023 | USD 197.96 | -3.26% |
|
United States |
|
17 |
USD 2.82 B
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
|
18 |
USD 2.64 B
|
June 30, 2024 | USD 173.13 | 0.11% |
|
Australia |
|
19 |
USD 2.63 B
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
20 |
USD 2.63 B
|
Dec. 31, 2023 | USD 0.34 | 2.88% |
|
China |
|
21 |
USD 2.38 B
|
Dec. 31, 2023 | USD 116.36 | -0.45% |
|
Germany |
|
22 |
USD 2.10 B
|
Dec. 31, 2023 | USD 143.06 | -4.74% |
|
United States |
|
23 |
USD 2.10 B
|
Dec. 31, 2023 | USD 234.50 | 0.17% |
|
United States |
|
24 |
USD 2.00 B
|
March 31, 2024 | USD 6.26 | 1.69% |
|
India |
|
25 |
USD 1.78 B
|
Dec. 31, 2023 | USD 47.49 | -5.41% |
|
Luxembourg |
|
26 |
USD 1.76 B
|
Dec. 31, 2023 | USD 0.25 | 2.80% |
|
China |
|
27 |
USD 1.70 B
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
28 |
USD 1.56 B
|
Dec. 31, 2023 | USD 411.66 | -0.41% |
|
United States |
|
29 |
USD 1.39 B
|
Dec. 31, 2023 | USD 27.55 | -1.02% |
|
Finland |
|
30 |
USD 1.32 B
|
Oct. 31, 2024 | USD 143.43 | 1.04% |
|
United States |
|
31 |
USD 1.30 B
|
Dec. 31, 2023 | USD 164.41 | -1.15% |
|
United States |
|
32 |
USD 1.29 B
|
Dec. 31, 2023 | USD 6.95 | 4.11% |
|
China |
|
33 |
USD 1.26 B
|
Dec. 31, 2023 | USD 49.86 | 0.81% |
|
Germany |
|
34 |
USD 1.15 B
|
Dec. 31, 2023 | USD 21.72 | -1.36% |
|
United States |
|
35 |
USD 1.07 B
|
Dec. 31, 2023 | USD 17.64 | -3.66% |
|
United States |
|
36 |
USD 990.63 M
|
March 31, 2024 | USD 18.62 | 0.90% |
|
Japan |
|
37 |
USD 987.50 M
|
Dec. 31, 2023 | USD 79.17 | -0.84% |
|
United States |
|
38 |
USD 962.69 M
|
March 31, 2024 | USD 15.45 | 0.33% |
|
India |
|
39 |
USD 908.30 M
|
Dec. 31, 2023 | USD 5.03 | -1.57% |
|
United Kingdom |
|
40 |
USD 895.12 M
|
Dec. 31, 2023 | USD 9.29 | 3.24% |
|
Spain |
|
41 |
USD 892.00 M
|
Dec. 31, 2023 | USD 34.46 | -1.96% |
|
United States |
|
42 |
USD 871.08 M
|
Dec. 31, 2023 | USD 2.26 | 4.12% |
|
China |
|
43 |
USD 864.10 M
|
Dec. 31, 2023 | USD 6.04 | 3.46% |
|
China |
|
44 |
USD 847.68 M
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
45 |
USD 832.88 M
|
Dec. 31, 2023 | USD 2.05 | 4.96% |
|
China |
|
46 |
USD 811.54 M
|
March 31, 2024 | USD 14.22 | -0.40% |
|
Japan |
|
47 |
USD 780.38 M
|
Dec. 30, 2023 | USD 178.08 | -6.34% |
|
United States |
|
48 |
USD 775.09 M
|
Dec. 31, 2023 | USD 30.03 | 0.13% |
|
United States |
|
49 |
USD 760.50 M
|
Dec. 31, 2023 | USD 3.54 | 2.01% |
|
China |
|
50 |
USD 752.00 M
|
Dec. 31, 2023 | USD 136.48 | -5.37% |
|
United States |
The Biotechnology company with the highest Receivables is Bristol-Myers Squibb Company (NYSE: BMY) at USD 15.26 B.
The Biotechnology company with the lowest Receivables is Genting Plantations Berhad (Kuala Lumpur Stock Exchange: 2291.KL) at USD -3.41 M.
The top 10 Biotechnology companies the Global by Receivables are Bristol-Myers Squibb Company, Pfizer Inc., AbbVie Inc., Bayer Aktiengesellschaft, Thermo Fisher Scientific Inc., Novartis AG, AstraZeneca PLC, Amgen Inc., Regeneron Pharmaceuticals, Inc. and Corteva, Inc..
The bottom 10 Biotechnology companies by Receivables are Genting Plantations Berhad, Zhongzhu Healthcare Holding Co.,Ltd, SynBiotic SE, NEXT Biometrics Group ASA, ABL Bio Inc., Larimar Therapeutics, Inc., ExpreS2ion Biotech Holding AB (publ), Arcellx, Inc., Acrivon Therapeutics, Inc. Common Stock and Cellid, Co., Ltd..